MedPath

Lindholm, Peter

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela

Phase 2
Withdrawn
Conditions
Covid19
Interventions
Combination Product: Hyperbaric oxygen therapy
First Posted Date
2021-05-28
Last Posted Date
2024-01-23
Lead Sponsor
Peter Lindholm
Registration Number
NCT04905888
Locations
🇺🇸

Univeristy of California San Diego, La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath